By StreetInsider.com
Publication Date: 2026-03-09 12:00:00
Freedom Capital Markets analyst Gene Mannheimer lowered his price target on Nutanix (NASDAQ: NTNX) to $215.00 (from $220.00), while maintaining a Buy rating. The analyst comments: “We reiterate our…



